<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Fu Z</submitter><pubmed_abstract>The starvation therapy mediated by the lonidamine (LND) was limited by the low drug delivery efficiency, off-target effect and compensative glutamine metabolism. Herein, a hyaluronic acid (HA)-modified reduction-responsive micellar nanosystem co-loaded with glycolysis and glutamine metabolism inhibitor (LND and bis-2-(5-phenylacetmido-1,2,4-thiadiazol-2-yl)ethyl sulfide, BPTES) was constructed for tumor-targeted dual-starvation therapy. The in vitro and in vivo results collectively suggested that the fabricated nanosystem could effectively endocytosed by tumor cells via HA receptor-ligand recognition, and rapidly release starvation-inducers LND and BPTES in response to the GSH-rich intratumoral cytoplasm. Furthermore, the released LND and BPTES were capable of inducing glycolysis and gluta</pubmed_abstract><journal>Materials today. Bio</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9552111</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Tumor-targeted dual-starvation therapy based on redox-responsive micelle nanosystem with co-loaded LND and BPTES</pubmed_title><pmcid>PMC9552111</pmcid><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Meng S</pubmed_authors><pubmed_authors>Zheng X</pubmed_authors><pubmed_authors>Dai L</pubmed_authors><pubmed_authors>Yao M</pubmed_authors><pubmed_authors>Zhao P</pubmed_authors><pubmed_authors>Fu Z</pubmed_authors><pubmed_authors>Du H</pubmed_authors><pubmed_authors>Cai K</pubmed_authors><pubmed_authors>Yuan Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tumor-targeted dual-starvation therapy based on redox-responsive micelle nanosystem with co-loaded LND and BPTES</name><description>The starvation therapy mediated by the lonidamine (LND) was limited by the low drug delivery efficiency, off-target effect and compensative glutamine metabolism. Herein, a hyaluronic acid (HA)-modified reduction-responsive micellar nanosystem co-loaded with glycolysis and glutamine metabolism inhibitor (LND and bis-2-(5-phenylacetmido-1,2,4-thiadiazol-2-yl)ethyl sulfide, BPTES) was constructed for tumor-targeted dual-starvation therapy. The in vitro and in vivo results collectively suggested that the fabricated nanosystem could effectively endocytosed by tumor cells via HA receptor-ligand recognition, and rapidly release starvation-inducers LND and BPTES in response to the GSH-rich intratumoral cytoplasm. Furthermore, the released LND and BPTES were capable of inducing glycolysis and gluta</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-29T10:59:31.152Z</modification><creation>2025-02-19T01:01:56.67Z</creation></dates><accession>S-EPMC9552111</accession><cross_references/></HashMap>